Curative effect of motherwort combined with ethinylestradiol-cyproterone acetate on dysfunctional uterine bleeding

Abstract

ABSTRACT Objective Thisstudy aimed to investigate the curative effect of motherwort combinedwith ethinylestradiol-cyproterone acetate (EE/CPA) on dysfunctionaluterine bleeding (DUB). Methods Atotal of 68 patients with DUB were divided into a single medicationgroup (treated with EE/CPA) and a combination medication group(treated with motherwort and EE/CPA). The clinical efficacy, uterinehemodynamic parameters, sex hormone levels, coagulation index levels,blood routine test levels, and adverse reactions of patients wereevaluated. Results Afterthree months of treatment, total treatment response rate of thecombination medication group was significantly higher than that ofthe single medication group. Decreased uterine volume, endometrialthickness and resistance index (RI), increased pulsatility index(PI), average flow rate, and uterine artery blood flow, as well asreduced follicle-stimulating hormone (FSH), luteinizing hormone (LH),estradiol (E2), progesterone (P), activated partial thromboplastintime (aPTT), prothrombin time (PT), fibrinogen (FIB), thrombin time(TT), platelet count (PLT), red blood cell (RBC), and hemoglobin (Hb)levels were witnessed in patients of the two groups. In thecombination medication group, there exhibited reduced uterine volume,endometrial thickness and RI, elevated PI, average flow rate, anduterine artery blood flow, reduced P, E2, FSH, LH, aPTT, PT, FIB, TT,PLT, RBC, and Hb levels in comparison to the single medication group. Conclusion Thecombination of motherwort and EE/CPA is clinically effective in thetreatment of DUB.